[Meta-analysis of the effects on hormone replacement therapy and oral contraceptives associated with female lung cancer risk].
To evaluate the effects of hormone replacement therapy (HRT) and oral contraceptives (OCs) on lung cancer risk in women. We retrieved studies by systematically searching Medline and other computerized databases. Pooled odds ratios (OR) were appropriately derived from fixed-effects or, in the presence of heterogeneity, random-effects models. Twelve studies were identified including 3 cohort studies and 9 case-control studies. The OR value associated with HRT was 0.88 (95% CI: 0.77-1.01). Subgroup analyses by smoking revealed that the OR value associated with HRT in smokers' and non-smokers' women were 0.76(95% CI: 0.61-0.95) and 0.78 (95% CI: 0.64-0.95), respectively. There was no statistical relationship between lung cancer risk and OCs (OR = 0.95; 95% CI: 0.83-1.20). The results suggest a potential decreased risk of female lung cancer might be associated with HRT. Additional well-designed studies are warranted to validate these findings.